Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Ocular Therapeutix, Inc. (OCUL): A Bull Case Theory 

We came across a bullish thesis on Ocular Therapeutix, Inc. on r/Valueinvesting by Senior-Preference678. In this article, we will summarize the bulls’ thesis on OCUL. Ocular Therapeutix, Inc.'s share was trading at $8.88 as of February 16th.

[caption id="attachment_575909" align="aligncenter" width="750"] l i g h t p o e t/Shutterstock.com[/caption]

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in...